Sec Form 4 Filing - Kessler Jon @ HEALTHEQUITY, INC. - 2020-03-31

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
Kessler Jon
2. Issuer Name and Ticker or Trading Symbol
HEALTHEQUITY, INC. [ HQY]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X __ Director _____ 10% Owner
X __ Officer (give title below) _____ Other (specify below)
President and CEO
(Last) (First) (Middle)
15 WEST SCENIC POINTE DRIVE, SUITE 100
3. Date of Earliest Transaction (MM/DD/YY)
03/31/2020
(Street)
DRAPER, UT84020
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/31/2020 A 26,643 ( 1 ) A $ 0 469,053 D
Common Stock 03/31/2020 A 12,076 ( 2 ) A $ 0 481,129 D
Common Stock 03/31/2020 A 66,756 A $ 0 547,885 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) $ 41.28 02/07/2020 G( 3 ) 17,410 ( 4 ) 03/27/2027 Common Stock 52,229 $ 0 34,819 D
Stock Option (right to buy) $ 41.28 02/07/2020 G( 3 ) 17,410 ( 5 ) 03/27/2027 Common Stock 17,410 $ 0 17,410 I by GKF, LLC
Stock Option (right to buy) $ 61.72 02/07/2020 G( 3 ) 11,965 ( 6 ) 03/27/2028 Common Stock 47,859 $ 0 35,894 D
Stock Option (right to buy) $ 61.72 02/07/2020 G( 3 ) 11,965 ( 5 ) 03/27/2028 Common Stock 11,965 $ 0 11,965 I by GKF, LLC
Stock Option (right to buy) $ 14 02/07/2020 G( 3 ) 160,000 ( 5 ) 07/30/2024 Common Stock 160,000 $ 0 0 D
Stock Option (right to buy) $ 14 02/07/2020 G( 3 ) 160,000 ( 5 ) 07/30/2024 Common Stock 160,000 $ 0 160,000 I by GKF, LLC
Stock Option (right to buy) $ 73.61 ( 7 ) 03/26/2029 Common Stock 51,125 51,125 D
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Kessler Jon
15 WEST SCENIC POINTE DRIVE, SUITE 100
DRAPER, UT84020
X President and CEO
Signatures
/s/ Jon Kessler 04/02/2020
Signature of Reporting Person Date
Explanation of Responses:
( 1 )Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest as to 26,643 shares on the date of the meeting of the Company's compensation committee to be held in the first quarter of the fiscal year ended January 31, 2022.
( 2 )Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest as to 12,076 shares on the date of the meeting of the Company's compensation committee to be held in the first quarter of the fiscal year ended January 31, 2023.
( 3 )This transaction involved a gift of options by the reporting person to GKF, LLC (the "LLC"). The reporting person and his wife, who is a member of his immediate family, serve as co-managers of the LLC, which is wholly owned by the Jon Kessler and Laura M. Gottsman Family Trust (the "Trust"), of which the reporting person and his wife are co-trustees. The reporting person and members of his immediate family are the sole beneficiaries of the Trust.
( 4 )The option became exercisable as to 17,410 shares on March 27, 2020. The remaining 17,409 shares will vest on March 27, 2021.
( 5 )The option is immediately exercisable.
( 6 )The option became exercisable as to 11,965 shares on March 27, 2020. The option will vest as to 11,965 shares on March 27, 2021 and 11,964 shares on March 27, 2022.
( 7 )The option vested as to 12,782 shares on March 26, 2020. The remaining options will vest in annual installments of 12,781 on each of March 26, 2021, 2022 and 2023.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.